Valuation: aap Implantate AG

Market Cap 21.84M 24.91M 20.19M 18.56M 35.03M 2.4B 35.59M 241M 94.62M 1.18B 93.55M 91.51M 4.05B P/E 2024
-3.6x
P/E 2025 -7.58x
Enterprise Value 21.52M 24.56M 19.9M 18.3M 34.52M 2.37B 35.08M 238M 93.26M 1.16B 92.21M 90.2M 3.99B EV / Sales 2024
1.31x
EV / Sales 2025 1.52x
Free-Float
38.21%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 2019-04-30
Director TitleAgeSince
Director/Board Member 70 2015-12-31
Chairman 54 2019-07-03
Director/Board Member 50 2021-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-9.32% - - 24.91M
+0.97%+10.37%-17.80%-9.09% 177B
+0.11%-0.34%-7.05%-6.78% 107B
-1.27%-0.70%+3.80%+57.17% 59.14B
+0.93%-0.47%+41.62%+62.05% 51.89B
-2.33%+0.42%-13.63%-41.35% 42.57B
-2.29%-4.19% - - 32.88B
-1.25%-0.86%-9.77%-42.07% 29.21B
-1.65%-2.05%+67.06%-6.98% 24.89B
-1.55%-1.19%-4.93%-6.81% 20.9B
Average -1.10%+0.27%+7.41%+0.77% 60.57B
Weighted average by Cap. -0.23%+2.91%-1.60%+1.88%

Financials

2024 2025
Net sales 12.29M 14.03M 11.36M 10.45M 19.72M 1.35B 20.03M 136M 53.26M 662M 52.66M 51.52M 2.28B 12.8M 14.61M 11.84M 10.89M 20.54M 1.41B 20.87M 142M 55.48M 689M 54.85M 53.66M 2.37B
Net income -3.63M -4.14M -3.36M -3.09M -5.82M -399M -5.92M -40.12M -15.73M -195M -15.55M -15.21M -673M -2.58M -2.95M -2.39M -2.2M -4.15M -284M -4.21M -28.57M -11.2M -139M -11.07M -10.83M -479M
Net Debt -1.1M -1.26M -1.02M -936K -1.77M -121M -1.79M -12.17M -4.77M -59.27M -4.72M -4.61M -204M -314K -358K -290K -267K -504K -34.55M -512K -3.47M -1.36M -16.9M -1.35M -1.32M -58.24M
Logo aap Implantate AG
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Employees
-